Walleye Capital LLC Buys Shares of 39,265 Enhabit, Inc. $EHAB

Key Points

• Walleye Capital LLC purchased 39,265 shares of Enhabit, Inc. for approximately $345,000, representing a 0.08% stake in the company according to SEC filings.
• UBS Group lowered their price target for Enhabit from $10.00 to $8.50, maintaining a "neutral" rating, while the overall consensus rating for the stock remains "Hold" with an average price target of $8.67.
• Chief Financial Officer Ryan Solomon acquired 10,000 shares of Enhabit at $7.64 per share, increasing his ownership to approximately $1.48 million in total shares.

Walleye Capital LLC purchased a new stake in shares of Enhabit, Inc. (NYSE:EHAB - Free Report) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 39,265 shares of the company's stock, valued at approximately $345,000. Walleye Capital LLC owned approximately 0.08% of Enhabit at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of EHAB. D. E. Shaw & Co. Inc. grew its holdings in shares of Enhabit by 33.2% during the fourth quarter. D. E. Shaw & Co. Inc. now owns 1,004,215 shares of the company's stock valued at $7,843,000 after buying an additional 250,215 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of Enhabit by 12.3% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,953,941 shares of the company's stock valued at $15,260,000 after buying an additional 213,774 shares in the last quarter. Nuveen LLC purchased a new position in shares of Enhabit during the first quarter valued at $1,773,000. Systematic Financial Management LP grew its holdings in shares of Enhabit by 8.6% during the fourth quarter. Systematic Financial Management LP now owns 1,996,113 shares of the company's stock valued at $15,590,000 after buying an additional 157,914 shares in the last quarter. Finally, Nuveen Asset Management LLC grew its holdings in shares of Enhabit by 95.5% during the fourth quarter. Nuveen Asset Management LLC now owns 265,361 shares of the company's stock valued at $2,072,000 after buying an additional 129,610 shares in the last quarter.

Insiders Place Their Bets

In related news, CFO Ryan Solomon bought 10,000 shares of the business's stock in a transaction on Friday, August 8th. The shares were bought at an average cost of $7.64 per share, for a total transaction of $76,400.00. Following the completion of the acquisition, the chief financial officer directly owned 193,468 shares in the company, valued at approximately $1,478,095.52. This represents a 5.45% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 3.40% of the stock is currently owned by company insiders.

Enhabit Stock Up 0.3%

Shares of EHAB stock traded up $0.02 on Tuesday, hitting $7.72. The company's stock had a trading volume of 99,097 shares, compared to its average volume of 446,625. The company has a debt-to-equity ratio of 0.79, a current ratio of 1.57 and a quick ratio of 1.57. Enhabit, Inc. has a fifty-two week low of $6.47 and a fifty-two week high of $10.90. The firm's fifty day moving average price is $7.37 and its 200-day moving average price is $8.45. The stock has a market capitalization of $391.38 million, a price-to-earnings ratio of -2.90 and a beta of 1.69.

Enhabit (NYSE:EHAB - Get Free Report) last posted its earnings results on Wednesday, August 6th. The company reported $0.13 EPS for the quarter, topping the consensus estimate of $0.10 by $0.03. Enhabit had a negative net margin of 12.84% and a positive return on equity of 2.72%. The firm had revenue of $266.10 million for the quarter, compared to the consensus estimate of $263.39 million. Research analysts anticipate that Enhabit, Inc. will post 0.22 EPS for the current year.

Wall Street Analyst Weigh In

Separately, UBS Group lowered their price target on Enhabit from $10.00 to $8.50 and set a "neutral" rating on the stock in a report on Friday, August 8th. One research analyst has rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of $8.67.

Enhabit Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.